Mission Statement
The National Cancer Institute (NCI) Clinical Trials and Translational Research Advisory Committee (CTAC) ad hoc Translational Research Strategy Subcommittee (TRSS) will convene an ad hoc Working Group on gastric and esophageal cancer to survey the scientific horizons broadly to:
- Identify translational research knowledge gaps related to gastric and esophageal cancer;
- Help identify the most provocative and impactful translational research questions to advance the diagnosis and treatment of gastric and esophageal cancer;
- Examine and identify the most important opportunities for application of new technologies to gastric and esophageal cancer translational research.
Working Group membership will include select CTAC, National Cancer Advisory Board (NCAB), and NCI Board of Scientific Advisors (BSA) members, as well as individuals with expertise in clinical and basic research, patient care, advocacy, and other expertise in gastric and esophageal cancer.
The Working Group will advise the TRSS, CTAC, NCAB, BSA, and the NCI Director.
Roster
Co-chairs
Karyn A. Goodman, M.D.
Professor, Radiation Oncology
Professor, Medicine, Hematology and Medical Oncology
Mount Sinai Hospital
New York, New York
Anil K. Rustgi, M.D.
Irving Professor of Medicine
Director, Herbert Irving Comprehensive Cancer Center
Columbia University Irving Medical Center
New York, New York
Members
Andrew Chan, M.D., M.P.H.
Chief, Clinical and Translational Epidemiology Unit
Director, Cancer Epidemiology
Mass General Cancer Center
Massachusetts General Hospital
Boston, Massachusetts
Marcia Cruz-Correa, M.D., Ph.D.
Professor of Medicine, Biochemistry and Surgery
University of Puerto Rico School of Medicine
Affiliated Investigator, Cancer Biology Division
University of Puerto Rico Comprehensive Cancer Center
San Juan, Puerto Rico
Lynn DeGregorio
President
DeGregorio Family Foundation
Pleasantville, New York
Ernest Hawk, M.D., M.P.H.
Vice President and Division Head
Cancer Prevention and Population Sciences
Department of Clinical Cancer Prevention
Division of Cancer Prevention and Population Sciences
University of Texas MD Anderson Cancer Center
Houston, Texas
Syma Iqbal, M.D.
Associate Professor of Clinical Medicine
Division of Oncology
Assistant Program Director
Oncology Department's Fellowship Program
University of Southern California
Los Angeles, California
David A. Mankoff, M.D., Ph.D.
Matthew J. Wilson Professor of Radiology
Vice-Chair for Research
Department of Radiology
Associate Director of Education and Training Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
Sanford Markowitz, M.D., Ph.D.
Ingalls Professor of Cancer Genetics
Department of Medicine
Professor, Department of Genetics and Genome Sciences
Professor, Department of Molecular Biology and Microbiology
Principal Investigator, Case GI SPORE
Case Comprehensive Cancer Center
Co-Leader, GI Cancer Genetics Program
Case Comprehensive Cancer Center
Case Western Reserve University School of Medicine
Cleveland, Ohio
Martin McCarter, M.D.
Professor of Surgery
Surgical Director for the Gastric and Esophageal Multidisciplinary Clinic
University of Colorado Denver
Aurora, Colorado
Richard M. Peek, Jr., M.D.
Director, Division of Gastroenterology
Professor of Medicine
Mina Cobb Wallace Chair in Immunology
Professor of Pathology, Microbiology and Immunology
Vanderbilt University Medical Center
Nashville, Tennessee
Philip Agop Philip, M.D., Ph.D.
Kathryn Cramer Endowed Chair in Cancer Research
Professor of Oncology and Pharmacology
Vice President of Medical Affairs
Karmanos Cancer Institute
Wayne State University
Detroit, Michigan
Manish A. Shah, M.D.
Professor of Medicine
Bartlett Family Professor in Gastrointestinal Oncology
Weill Cornell Medical College
New York, New York
Ex Officio Members
Philip E. Castle, Ph.D.
Director
Division of Cancer Prevention
National Cancer Institute
National Institutes of Health
Bethesda, Maryland
Maria Constanza Camargo, Ph.D.
Earl Stadtman Investigator
Metabolic Epidemiology Branch
Division of Cancer Epidemiology and Genetics
National Cancer Institute
National Institutes of Health
Bethesda, Maryland
James H. Doroshow, M.D.
Deputy Director
Clinical and Translational Research
Director
Division of Cancer Treatment and Diagnosis
National Cancer Institute
National Institutes of Health
Bethesda, Maryland
Jeremy L. Davis, M.D.
Associate Research Physician
Surgical Oncology Program
Center for Cancer Research
National Cancer Institute
National Institutes of Health
Bethesda, Maryland
Executive Secretary
Iris Castro, M.P.H.
Scientific Program Specialist
Coordinating Center for Clinical Trials
Office of the Director
National Cancer Institute
National Institutes of Health
Bethesda, Maryland